SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/95E4334118B027E423B609F39BB5E58170807A48206CFFD4A438C7615E89591D643510DD3100504B0740E35917720F29>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/95E4334118B027E423B609F39BB5E58170807A48206CFFD4A438C7615E89591D643510DD3100504B0740E35917720F29
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/95E4334118B027E423B609F39BB5E58170807A48206CFFD4A438C7615E89591D643510DD3100504B0740E35917720F29
http://www.w3.org/2000/01/rdf-schema#comment
"These parallel in vivo and in vitro data suggest that HLA-B57 confers its advantage primarily by driving and maintaining a fitness-attenuating mutation in p24-Gag."
xsd:string
http://purl.uniprot.org/uniprot/#_D4C61B7B32CEC4EFD492939AB80C952E9ACCA98BB61F446028EB2677067160056B8B800FC9E681567C9334D0EB1F03BD
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/95E4334118B027E423B609F39BB5E58170807A48206CFFD4A438C7615E89591D643510DD3100504B0740E35917720F29
http://purl.uniprot.org/uniprot/L0BXM2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/95E4334118B027E423B609F39BB5E58170807A48206CFFD4A438C7615E89591D643510DD3100504B0740E35917720F29
http://purl.uniprot.org/uniprot/#_L0BXM2-mappedCitation-19515764
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/95E4334118B027E423B609F39BB5E58170807A48206CFFD4A438C7615E89591D643510DD3100504B0740E35917720F29